"Moreover, the duration of follow-up is among the longest reported for a lentiviral vector-based gene therapy; 13 patients ...

As tariffs, HHS workforce cuts and the ouster of CBER Director Peter Marks threaten the “lifeblood” of the cell and gene ...

Dr. Soliman Abdel Kader Fakeeh Hospital Co. (Fakeeh Care) and its subsidiaries, Fakeeh Care Group and Fakeeh Care, signed a ...

Navigate the complexities of cell and gene therapy (CGT) supply chains with the 6 th Supply Chain & Logistics for Cell & Gene Therapies Summit. The official event guide is your practical roadmap ...

The Global Cell And Gene Therapy Market is valued at USD 20.5 Billion in 2024 and is projected to reach a value of USD 128.8 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 18.2% between ...

The CRISPR company is laying off about a third of its employees and stopping work on an experimental lupus treatment in a bid ...

If administered early, gene therapy has the potential to change the medical history of children born with metachromatic leukodystrophy (MLD), a rare and lethal neurodegenerative disease of genetic ...

Laurus aims to leverage India's manufacturing prowess to serve global cell and gene therapy players targeting the Indian ...

Martin, 20, was the first patient in St. Louis and among the first across the country to receive a new gene therapy for sickle cell disease. The monthslong therapy involves extracting a patient ...

One assay applies to bioprocesses that use the HEK293 human embryonic kidney cell line, often used in gene therapy development.

People with diseases caused by rare mutations have fewer options and poorer prospects than other patients despite rapid ...